Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert W. Pangia currently holds 16,000 shares of BIOGEN IDEC INC. (BIIB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert W. Pangia has been a net seller of BIIB stock. They have purchased $1.0M and sold $31.8M worth of shares.
Robert W. Pangia's most recent insider trade was on Dec 31, 2020, when they sold 16,000 shares at $0.00 per share.
Robert W. Pangia serves as Executive at BIOGEN IDEC INC. (BIIB). They have executed 165 insider transactions totaling $32.8M over their tenure at the company.
Robert W. Pangia holds the position of Executive at BIOGEN IDEC INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Robert W. Pangia has shown a selling trading pattern, with $1.0M in total purchases and $31.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert W. Pangia was on Mar 18, 2019, when they sold $2.0M worth of BIIB shares. This transaction involved 6,114 shares at $328.55 per share.
Robert W. Pangia currently owns 16,000 shares of BIOGEN IDEC INC. (BIIB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert W. Pangia's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert W. Pangia has 165 Form 4 filings on record as an insider at BIOGEN IDEC INC..
Set alerts for Robert W. Pangia and 40,000+ other insiders.